Pathophysiology Quiz: Neurodegenerative Diseases

20 questions · exam conditions

0:00

Neurodegenerative DiseasesQuestion 1 of 20

The cholinergic hypothesis of Alzheimer's disease posits that cognitive decline is partly due to a deficit in acetylcholine (ACh). This deficit is a direct result of the degeneration of cholinergic neurons primarily located in which brain structure?

Substantia nigra pars compacta

Ventral tegmental area

Locus coeruleus

Nucleus basalis of Meynert

← Back to quizzes

Pathophysiology Quiz

Pathophysiology Quiz: Neurodegenerative Diseases

Practice Neurodegenerative Diseases in Pathophysiology with focused quiz questions that help you check what you know, review explanations, and build confidence with test-style prompts.

What this quiz covers

This quiz focuses on Neurodegenerative Diseases, giving you a quick way to practice the rules, question types, and explanations that matter most for Pathophysiology.

How to use this quiz

Try each quiz question before looking at the correct answer. Use the explanations to review missed ideas, then come back to similar questions until the pattern feels familiar.

All questions

Question 1

Substantia nigra pars compacta
Ventral tegmental area
Locus coeruleus
Nucleus basalis of Meynert (correct answer)

Explanation: The nucleus basalis of Meynert, located in the basal forebrain, is the primary source of cholinergic innervation to the cerebral cortex. In Alzheimer's disease, there is profound and relatively early degeneration of these specific neurons. The resulting loss of cortical acetylcholine is a major contributor to the memory and attention deficits seen in the disease. This is the basis for using acetylcholinesterase inhibitors as a symptomatic treatment. The substantia nigra (A) and ventral tegmental area (B) are dopaminergic nuclei, while the locus coeruleus (C) is the principal noradrenergic nucleus.

Question 2

While α-synuclein is primarily known for its role in Parkinson's disease pathology, it is a normally abundant presynaptic protein. What is the proposed physiological function of α-synuclein in a healthy neuron?

It acts as a chaperone protein that directly facilitates the folding of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis.
It is a microtubule-associated protein that, like tau, is essential for maintaining the stability and integrity of the axonal cytoskeleton.
It functions as a transcription factor that regulates the expression of genes involved in mitochondrial biogenesis and function.
It modulates synaptic vesicle trafficking and neurotransmitter release by interacting with SNARE complex components and phospholipids. (correct answer)

Explanation: In its normal, soluble form, α-synuclein is highly expressed at presynaptic terminals. It is believed to play a crucial role in regulating synaptic vesicle dynamics. Evidence suggests it interacts with membrane phospholipids and proteins of the SNARE complex to modulate the clustering, docking, and fusion of synaptic vesicles, thereby influencing neurotransmitter release. The other options describe functions not attributed to α-synuclein: A) it does not chaperone tyrosine hydroxylase; B) it is not a primary microtubule-stabilizing protein like tau; C) it is a cytosolic/presynaptic protein, not a nuclear transcription factor.

Question 3

Oxidative stress is a significant contributor to the death of dopaminergic neurons in Parkinson's disease. A major source of this stress arises from the normal enzymatic metabolism of which molecule within these specific neurons?

Acetylcholine by acetylcholinesterase, which generates hydrogen peroxide as a byproduct.
α-synuclein by the proteasome, which releases free iron that catalyzes Fenton reactions.
Dopamine by monoamine oxidase (MAO), which produces hydrogen peroxide as a reactive byproduct. (correct answer)
Glutamate by glutaminase, a process that uncouples the mitochondrial electron transport chain.

Explanation: Dopaminergic neurons face a high intrinsic level of oxidative stress due to the metabolism of dopamine itself. When dopamine is broken down by monoamine oxidase (MAO) in the cytoplasm or at the mitochondrial outer membrane, hydrogen peroxide (H₂O₂) is generated as a byproduct. In the presence of free iron, which is also abundant in the substantia nigra, H₂O₂ can be converted into the highly reactive hydroxyl radical via the Fenton reaction, causing significant oxidative damage to lipids, proteins, and DNA. The other options describe processes that are not the primary source of intrinsic oxidative stress related to a unique feature of these neurons.

Question 4

A potential therapeutic strategy for Parkinson's disease involves increasing the clearance of α-synuclein aggregates. Which two cellular protein degradation systems are primarily responsible for clearing α-synuclein, and how are their roles differentiated?

The ubiquitin-proteasome system (UPS) degrades soluble monomers, while chaperone-mediated autophagy (CMA) degrades larger, insoluble aggregates.
The UPS degrades soluble, misfolded α-synuclein, while macroautophagy is primarily responsible for clearing larger oligomers and aggregates. (correct answer)
Macroautophagy is the sole pathway for all forms of α-synuclein, and its impairment is the primary cause of aggregation.
Endoplasmic reticulum-associated degradation (ERAD) clears monomers, while the UPS is responsible for degrading oligomers within Lewy bodies.

Explanation: Both the UPS and the autophagy-lysosome pathway are involved in α-synuclein degradation. The UPS is generally responsible for degrading soluble, monomeric, and small oligomeric forms of misfolded proteins after they are tagged with ubiquitin. However, when α-synuclein forms larger, more complex aggregates, or when the UPS is overwhelmed, the cell relies on macroautophagy to engulf these aggregates in autophagosomes and deliver them to the lysosome for degradation. A) reverses the role of CMA and macroautophagy regarding aggregate size. C) is incorrect as the UPS plays a significant role. D) ERAD deals with proteins in the ER, and the UPS degrades soluble proteins, not large aggregates within Lewy bodies.

Question 5

Early attempts at developing Alzheimer's therapies by targeting γ-secretase with potent inhibitors failed in clinical trials due to severe side effects. This was largely because γ-secretase cleaves many transmembrane proteins other than APP. The most critical of these alternative substrates, whose impaired processing causes serious adverse effects like gastrointestinal toxicity and immunosuppression, is which of the following?

Notch receptor (correct answer)
Apolipoprotein E receptor (ApoER2)
Epidermal growth factor receptor (EGFR)
TrkB receptor

Explanation: γ-secretase is an intramembrane-cleaving protease with numerous substrates, and the Notch receptor is one of the most physiologically critical. The cleavage of Notch by γ-secretase is an essential step in Notch signaling, a pathway vital for cell-fate determination in many tissues, including the gut epithelium and the immune system. Broad inhibition of γ-secretase disrupts this essential signaling pathway, leading to the severe mechanism-based toxicities observed in clinical trials. This has led to the development of γ-secretase modulators which aim to alter APP processing without affecting Notch cleavage.

Question 6

A research study investigates the neurotoxic species in Alzheimer's disease models. They observe that synaptic dysfunction and neuronal apoptosis correlate most strongly with the concentration of soluble, low-molecular-weight aggregates of amyloid-beta (Aβ), rather than with the total plaque load. This finding supports which concept in Alzheimer's pathophysiology?

The formation of large, insoluble amyloid plaques is a protective mechanism to sequester more toxic Aβ species. (correct answer)
Neurofibrillary tangles, not amyloid species, are the primary drivers of synaptic and neuronal loss in the disease.
Amyloid-beta is only neurotoxic after it has been cleaved from the amyloid precursor protein by α-secretase.
The total number of amyloid plaques directly reflects the rate of neuronal apoptosis in the affected brain region.

Explanation: This question addresses the evolving understanding of Aβ toxicity. Current evidence suggests that small, soluble Aβ oligomers are the most synaptotoxic and neurotoxic species. The formation of large, insoluble, dense-core plaques may represent a biological attempt to sequester these harmful oligomers into a less reactive state. Therefore, the observation that soluble aggregates, not total plaque load, correlate with neurotoxicity supports the idea that plaques could be a form of sequestration. B is contradicted by the stem, which focuses on Aβ species. C is incorrect; α-secretase cleavage is part of the non-amyloidogenic pathway and prevents Aβ formation. D is directly refuted by the findings described in the stem.

Question 7

A 72-year-old male is diagnosed with sporadic Alzheimer's disease. Genetic testing reveals he is homozygous for the apolipoprotein E ε4 (ApoE4) allele. Which statement best describes the primary mechanism by which this genetic factor contributes to his disease pathophysiology?

ApoE4 directly increases the catalytic activity of β-secretase (BACE1), leading to elevated production of amyloid-beta peptides from APP.
The ApoE4 protein isoform is less effective at mediating the clearance of amyloid-beta oligomers from the brain interstitial fluid. (correct answer)
The ApoE4 allele contains a mutation that causes misfolding and intracellular aggregation of the ApoE protein, forming a key component of neurofibrillary tangles.
ApoE4 enhances the hyperphosphorylation of tau protein by upregulating glycogen synthase kinase 3 beta (GSK-3β), independent of amyloid pathology.

Explanation: The ApoE4 allele is the strongest genetic risk factor for late-onset Alzheimer's disease. Its protein product, ApoE4, is primarily implicated in the clearance of amyloid-beta (Aβ). Compared to other isoforms like ApoE2 and ApoE3, ApoE4 is less efficient at binding to Aβ and facilitating its removal from the brain, leading to Aβ accumulation. A) ApoE4 does not directly alter secretase activity. C) ApoE protein is not a component of neurofibrillary tangles; tau protein is. D) While ApoE4 is associated with increased tau pathology, this is thought to be downstream of its effects on Aβ accumulation, not a direct, independent effect on tau kinases.

Question 8

While cognitive deficits are the hallmark of Alzheimer's disease (AD) and motor symptoms are central to Parkinson's disease (PD), there is some overlap in their underlying neurochemical pathology. Which statement best describes a key neurotransmitter system deficit, other than the primary one, that is common in later stages of both disorders?

Both diseases are characterized by a profound and early loss of serotonergic neurons in the dorsal raphe nucleus.
A significant loss of cholinergic neurons originating in the basal forebrain occurs in both advanced AD and PD dementia. (correct answer)
Both disorders involve a selective, early degeneration of noradrenergic neurons in the locus coeruleus.
A primary glutamatergic deficit resulting from excitotoxicity is the common terminal pathway for neuronal loss in both AD and PD.

Explanation: While the primary deficit in AD is cholinergic and in PD is dopaminergic, both diseases exhibit degeneration of other neurotransmitter systems as they progress. A significant loss of cholinergic neurons in the basal forebrain (e.g., nucleus basalis of Meynert) is a hallmark of AD, causing memory and attention deficits. This same system also degenerates in Parkinson's disease, particularly in patients who develop dementia (PDD), contributing significantly to their cognitive decline. A and C describe pathology that does occur in both diseases, but the cholinergic deficit is a more prominent and clinically significant shared feature related to cognitive decline. D is incorrect; excitotoxicity is a mechanism of cell death, but the primary pathology is not a deficit of glutamate, but rather its overactivity.

Question 9

In a healthy neuron, the primary function of tau protein is to bind to and stabilize microtubules. In Alzheimer's disease, tau becomes hyperphosphorylated. What is the most immediate consequence of this hyperphosphorylation on tau's function?

It causes tau to immediately aggregate into paired helical filaments, forming large neurofibrillary tangles.
It enhances tau's binding affinity for microtubules, making the cytoskeleton excessively rigid and brittle.
It promotes the cleavage of tau by caspases, generating neurotoxic fragments that accumulate in the mitochondria.
It reduces tau's affinity for microtubules, causing it to detach and leading to microtubule instability and impaired axonal transport. (correct answer)

Explanation: The phosphorylation state of tau regulates its binding to microtubules. Hyperphosphorylation adds negative charges to the tau protein, which electrostatically repels it from the negatively charged microtubule surface. This detachment is the initial key step in tau pathology. The consequences are twofold: 1) microtubules become unstable, and 2) the detached, soluble tau is now free to misfold and aggregate. A) Aggregation is a subsequent step, not the most immediate one. B) The effect is the opposite; affinity is reduced. C) While tau can be cleaved by caspases, this is not the primary and most immediate functional consequence of hyperphosphorylation itself.

Question 10

Exposure to the neurotoxin MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) can induce a clinical syndrome that closely mimics Parkinson's disease. The active metabolite of MPTP, MPP+, causes selective destruction of dopaminergic neurons. What is the specific cellular mechanism of MPP+ toxicity?

It potently and specifically inhibits Complex I (NADH dehydrogenase) of the mitochondrial electron transport chain. (correct answer)
It directly cross-links α-synuclein proteins, rapidly seeding the formation of Lewy body-like inclusions.
It acts as a false neurotransmitter, displacing dopamine from synaptic vesicles and causing excitotoxicity.
It blocks the reuptake of dopamine by the dopamine transporter (DAT), leading to oxidative stress in the synaptic cleft.

Explanation: When you encounter questions about neurotoxins that mimic Parkinson's disease, focus on the underlying cellular mechanisms that lead to dopaminergic neuron death. MPTP toxicity is a classic example of how mitochondrial dysfunction drives neurodegeneration. MPTP itself isn't toxic—it becomes dangerous when metabolized to MPP+ by monoamine oxidase B in glial cells. Once formed, MPP+ is taken up by dopaminergic neurons through the dopamine transporter, where it specifically targets mitochondria. The key mechanism is that MPP+ potently inhibits Complex I (NADH dehydrogenase) of the electron transport chain, disrupting ATP production and generating reactive oxygen species that kill the neuron. This mitochondrial toxicity explains why MPTP exposure causes such a striking Parkinson's-like syndrome. Option B is incorrect because while α-synuclein aggregation occurs in Parkinson's disease, MPP+ doesn't directly cross-link these proteins—the neurodegeneration happens too rapidly for significant Lewy body formation. Option C mischaracterizes the mechanism; MPP+ doesn't act as a false neurotransmitter but rather as a mitochondrial toxin. Option D reverses the actual process—MPP+ uses the dopamine transporter to enter neurons rather than blocking it, and the primary damage occurs in mitochondria, not the synaptic cleft. Remember that MPTP toxicity is a powerful research model precisely because it reproduces the mitochondrial dysfunction seen in idiopathic Parkinson's disease. When studying neurodegenerative diseases, always consider how cellular energy production and oxidative stress contribute to neuronal death.

Question 11

In the pathophysiology of Parkinson's disease, the loss of dopaminergic neurons in the substantia nigra pars compacta leads to a functional imbalance in the basal ganglia direct and indirect pathways. What is the most immediate consequence of this dopamine depletion on striatal medium spiny neurons (MSNs)?

Increased stimulation of MSNs in the direct pathway and decreased stimulation of MSNs in the indirect pathway, leading to bradykinesia.
Decreased inhibition of MSNs in the direct pathway and increased inhibition of MSNs in the indirect pathway, leading to hyperkinesia.
Decreased stimulation of D1-receptor-expressing MSNs and reduced inhibition of D2-receptor-expressing MSNs, resulting in motor inhibition. (correct answer)
Global excitation of all striatal MSNs, leading to a breakdown of motor program selection and causing resting tremor.

Explanation: Dopamine has differential effects on the two main populations of striatal medium spiny neurons (MSNs). It stimulates the direct pathway via D1 receptors (excitatory) and inhibits the indirect pathway via D2 receptors (inhibitory). Therefore, dopamine depletion leads to decreased stimulation of the D1-MSNs (direct pathway) and a loss of inhibition (disinhibition) of the D2-MSNs (indirect pathway). Both of these changes result in increased inhibition of the thalamus and cortex, leading to the net effect of motor inhibition (bradykinesia, rigidity). A and B incorrectly describe the effects on the pathways. D is an oversimplification; the effects are specific to the D1 and D2 pathways, not a global excitation.

Question 12

Acetylcholine by acetylcholinesterase, which generates hydrogen peroxide as a byproduct.
α-synuclein by the proteasome, which releases free iron that catalyzes Fenton reactions.
Dopamine by monoamine oxidase (MAO), which produces hydrogen peroxide as a reactive byproduct. (correct answer)
Glutamate by glutaminase, a process that uncouples the mitochondrial electron transport chain.

Question 13

Notch receptor (correct answer)
Apolipoprotein E receptor (ApoER2)
Epidermal growth factor receptor (EGFR)
TrkB receptor

Question 14

The formation of large, insoluble amyloid plaques is a protective mechanism to sequester more toxic Aβ species. (correct answer)
Neurofibrillary tangles, not amyloid species, are the primary drivers of synaptic and neuronal loss in the disease.
Amyloid-beta is only neurotoxic after it has been cleaved from the amyloid precursor protein by α-secretase.
The total number of amyloid plaques directly reflects the rate of neuronal apoptosis in the affected brain region.

Question 15

The amyloid cascade hypothesis proposes a sequence of pathogenic events in Alzheimer's disease. According to the most widely accepted version of this hypothesis, what is the critical initiating event that sets the cascade in motion?

Hyperphosphorylation of tau protein, leading to microtubule destabilization and the formation of neurofibrillary tangles.
An imbalance between the production and clearance of amyloid-beta (Aβ) peptides, particularly the Aβ42 isoform. (correct answer)
Chronic activation of microglial cells, resulting in the release of pro-inflammatory cytokines that cause widespread neuronal damage.
A severe deficit in acetylcholine synthesis in the nucleus basalis of Meynert, leading to cognitive decline.

Explanation: The amyloid cascade hypothesis posits that the accumulation of amyloid-beta (Aβ) peptides, resulting from an imbalance in production and clearance, is the central and initiating event in Alzheimer's disease pathogenesis. This accumulation, especially of Aβ42, is believed to trigger a downstream cascade that includes neuroinflammation, synaptic dysfunction, tau hyperphosphorylation and tangle formation, and ultimately, neuronal death. The other options describe events (A, C, D) that are considered to be part of this downstream cascade or consequences of the disease process, not the primary initiating event according to this hypothesis.

Question 16

It causes tau to immediately aggregate into paired helical filaments, forming large neurofibrillary tangles.
It enhances tau's binding affinity for microtubules, making the cytoskeleton excessively rigid and brittle.
It promotes the cleavage of tau by caspases, generating neurotoxic fragments that accumulate in the mitochondria.
It reduces tau's affinity for microtubules, causing it to detach and leading to microtubule instability and impaired axonal transport. (correct answer)

Question 17

The processing of amyloid precursor protein (APP) can follow two mutually exclusive pathways. A novel experimental drug is shown to significantly upregulate the activity of ADAM10, a member of the 'a disintegrin and metalloproteinase' family. What would be the expected effect on amyloid-beta (Aβ) production?

Increased Aβ production, because ADAM10 is an alternative β-secretase that initiates the amyloidogenic pathway.
Decreased Aβ production, because ADAM10 acts as an α-secretase, cleaving APP within the Aβ sequence. (correct answer)
No change in Aβ production, as ADAM10 is primarily involved in the degradation of already-formed Aβ plaques.
A shift in Aβ isoform production, favoring Aβ42 over Aβ40, without changing the total amount of Aβ.

Explanation: ADAM10 is a major α-secretase in the brain. The α-secretase cleaves APP within the Aβ domain, a process that is part of the non-amyloidogenic pathway. Because this cleavage event precludes the formation of the intact Aβ peptide, upregulating α-secretase activity shunts APP processing towards this protective pathway and away from the amyloidogenic pathway initiated by β-secretase (BACE1). Therefore, enhancing ADAM10 activity would be expected to decrease Aβ production. A) ADAM10 is an α-secretase, not a β-secretase. C) Neprilysin and insulin-degrading enzyme are examples of enzymes that degrade Aβ; ADAM10 acts on APP. D) This effect is characteristic of γ-secretase modulators or PSEN mutations, not α-secretase activity.

Question 18

Both diseases are characterized by a profound and early loss of serotonergic neurons in the dorsal raphe nucleus.
A significant loss of cholinergic neurons originating in the basal forebrain occurs in both advanced AD and PD dementia. (correct answer)
Both disorders involve a selective, early degeneration of noradrenergic neurons in the locus coeruleus.
A primary glutamatergic deficit resulting from excitotoxicity is the common terminal pathway for neuronal loss in both AD and PD.

Question 19

It acts as a chaperone protein that directly facilitates the folding of tyrosine hydroxylase, the rate-limiting enzyme in dopamine synthesis.
It is a microtubule-associated protein that, like tau, is essential for maintaining the stability and integrity of the axonal cytoskeleton.
It functions as a transcription factor that regulates the expression of genes involved in mitochondrial biogenesis and function.
It modulates synaptic vesicle trafficking and neurotransmitter release by interacting with SNARE complex components and phospholipids. (correct answer)

Question 20

Substantia nigra pars compacta
Ventral tegmental area
Locus coeruleus
Nucleus basalis of Meynert (correct answer)